CAD 0.37
(-6.41%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 561.43 Million USD | 8.92% |
2022 | 515.44 Million USD | 15.6% |
2021 | 445.86 Million USD | -24.78% |
2020 | 592.76 Million CAD | 53.79% |
2019 | 385.43 Million CAD | 1140.3% |
2018 | 31.07 Million CAD | 1736.53% |
2017 | 1.69 Million CAD | -5.27% |
2016 | 1.78 Million CAD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 573 Million USD | 2.06% |
2024 Q2 | 434.09 Million USD | -24.24% |
2023 FY | 561.43 Million USD | 8.92% |
2023 Q4 | 561.43 Million USD | -7.7% |
2023 Q3 | 608.24 Million USD | 7.86% |
2023 Q2 | 563.9 Million USD | 3.58% |
2023 Q1 | 544.41 Million USD | 5.62% |
2022 Q3 | 613.74 Million CAD | 2.62% |
2022 Q2 | 598.08 Million CAD | -6.32% |
2022 Q1 | 638.46 Million CAD | 43.2% |
2022 Q4 | 515.44 Million CAD | -16.02% |
2021 Q4 | 445.86 Million CAD | -17.0% |
2021 Q3 | 537.18 Million CAD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Aurora Cannabis Inc. | 236.8 Million CAD | -137.088% |
Avicanna Inc. | 13.99 Million CAD | -3910.508% |
Avant Brands Inc. | 33.22 Million CAD | -1589.835% |
Cardiol Therapeutics Inc. | 8.45 Million CAD | -6541.008% |
Crescita Therapeutics Inc. | 5.77 Million CAD | -9620.064% |
Knight Therapeutics Inc. | 198.62 Million CAD | -182.663% |
MediPharm Labs Corp. | 10.93 Million CAD | -5035.665% |
OrganiGram Holdings Inc. | 26.83 Million CAD | -1992.393% |
Canopy Growth Corporation | 799.82 Million CAD | 29.806% |
Willow Biosciences Inc. | 3.23 Million CAD | -17244.173% |
Auxly Cannabis Group Inc. | 210.85 Million CAD | -166.261% |